Reversal of a potent investigational anticoagulant: Idraparinux with recombinant factor VIIa [2]

American Journal of Medicine

Volumn 118, Issue 10, 2005, Pages 1172-1173

  Dao, Andrew ^a   Tuan, Bertrand ^a   Carlson, Nicole ^a  

^a CALIFORNIA PACIFIC MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 10A; HEPARIN; IDRAPARINUX; RECOMBINANT BLOOD CLOTTING FACTOR 7A; XIMELAGATRAN;

AGED; ASPIRATION BIOPSY; BLEEDING; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DRUG MECHANISM; DRUG POTENCY; DRUG RESEARCH; HEMOPTYSIS; HUMAN; HUMAN CELL; HUMAN TISSUE; LETTER; LOBECTOMY; LUNG HEMORRHAGE; MALE; PRIORITY JOURNAL; THROMBOCYTOPHERESIS; THROMBOEMBOLISM;

AGED; ANTICOAGULANTS; ATRIAL FIBRILLATION; BIOPSY, FINE-NEEDLE; DRAINAGE; DRUGS, INVESTIGATIONAL; FACTOR VIIA; HEMOPTYSIS; HEMORRHAGE; HUMANS; INTERNATIONAL NORMALIZED RATIO; LUNG; LUNG NEOPLASMS; MALE; OLIGOSACCHARIDES; PULMONARY EMBOLISM; RECOMBINANT PROTEINS; THORACIC DISEASES;

EID: 26444556410     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjmed.2005.04.025     Document Type: Letter

References (5)

1. J.I. Weitz, S. Middeldorp, W. Geerts, J.A. Heit Thrombophilia and new anticoagulant drugs Hematology (Am Soc Hematol Educ Program) 2004 424 438
2. J. Ansell, J. Hirsh, L. Poller The pharmacology and management of the vitamin K antagonists (The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy) Chest 126 2004 204S 233S
3. J.M. Herbert, J.P. Herault, A. Bernat Biochemical and pharmacological properties of SANORG 34006, a potent and long-acting synthetic pentasaccharide Blood 91 1998 4197 4205
4. S. Schulmann, K. Wahlander, T. Lundstrom Secondary prevention of venous thromboembolism with the oral direct thrombin inhibitor Ximelagatran N Engl J Med 349 2003 1713 1721
5. N.R. Bijsterveld, R. Vink, E. Benien Recombinant factor VIIa reverses the anticoagulant effect of the long-acting pentasaccharide idraparinux in healthy volunteers Br J Haematol 124 2004 653 658